Active	Status	Sponsor type	Region	Phase	Filter
4 Active 11 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Alexander, John
NCT04142658: PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban	Terminated	3	863	US	Apixaban 5 MG, Apixaban 2.5 MG, Warfarin, On-X Aortic Mechanical Valve, On-X Ascending Aortic Prosthesis (AAP)	Artivion Inc., Duke Clinical Research Institute	Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Failure	12/22	12/22
NCT05785819: A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia	Recruiting	2	60	US	VLX-1005, 12-LOX enzyme inhibitor, Placebo, Inactive substance similar in appearance to VLX-1005	Veralox Therapeutics	Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia	12/24	03/25
Farmer, Adam D
No trials found